High systolic blood pressure (SBP) is a major risk factor for ischemic heart disease (IHD), the
leading cause of death worldwide. Using data from published observational studies and …

More than 70% of adults treated for primary hypertension will eventually require at least two
antihypertensive agents, either initially as combination therapy or as add-on therapy if …

Non-communicable diseases (NCDs) are the world's leading causes of death and disability,
with cardiovascular disease (CVD) accounting for half of NCD deaths. An ambitious global …

Blood pressure (BP) control rates among US adults taking antihypertensive medication have
not increased over the past decade. Many adults require 2 or more classes of …

Importance Low-dose combination (LDC) antihypertensives consisting of 3 or 4 blood
pressure (BP)–lowering drugs have emerged as a potentially important therapy for the initial …

Summary Background Single-pill combinations (SPCs) of three low-dose antihypertensive
drugs can improve hypertension control but are not widely available. A key issue for any …

Objective Evidence from randomised trials of pharmacological treatments on long-term
blood pressure (BP) reduction is limited. We investigated the antihypertensive drug effects …

Background: In LABBPS (Los Angeles Barbershop Blood Pressure Study), pharmacist-led
hypertension care in Los Angeles County Black-owned barbershops significantly improved …

Aim: This systematic review assessed and synthesized the factors that are associated with
self-care and home-based management of hypertension. Methods: The search of the articles …

Background Over half of patients with elevated blood pressure require multi-drug treatment
to achieve blood pressure control. However, multi-drug treatment may lead to lower …